Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
Tiotropium bromide is the only long-acting muscarinic antagonist (LAMA) approved for treatment of patients aged ≥6 years old who have symptoms of uncontrolled asthma. Results from several clinical trials have found that once-daily inhaled tiotropium bromide is safe and efficacious in 6- to 17-year-o...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2022-07-01
|
| Series: | Frontiers in Pediatrics |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fped.2022.896865/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|